Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, Ontario, CanadaDr. Peter Lin began his studies in the Faculty of Science and Engineering at the University of Toronto in Toronto, Ontario. Midway through, he moved to the Faculty of Medicine, where he completed his studies and became involved in research. Over the years, it became apparent to him that there was a wide chasm between research and clinical practice, and he moved into clinical practice in primary care and eventually into teaching in order to help bridge this gap. He served as the medical director at the Health & Wellness Centre, University of Toronto Scarborough, for 7 years.
Currently, Dr. Peter Lin is the Director of Primary Care Initiatives at the Canadian Heart Research Centre. He is also a contributing author to the Canadian Diabetes Guidelines 2013 and 2018 on the vascular protection section. He is also Associate Editor for the Elsevier WebPortal - PracticeUpdate Primary Care. He lectures and speaks internationally on a variety of topics. Dr. Lin has worked with KDIGO in order to help improve care for CKD patients. He has also been tracking and providing information on COVID-19 to the public since the beginning of the pandemic. Dr. Lin received a teaching award from the College of Family Physicians in 2011.
Disclosures
Dr. Lin has consulted with the following companies on Continuing Medical Education programs:Astrazeneca, Boeringher Ingelheim, Bayer, Eli Lilly, Amgen, Janssen, Merck, Pfizer, Sanofi, Abbott, HLS Therapeutics Inc.
No clinical trials. No patents.
Recent Contributions to PracticeUpdate:
- SGLT2 Inhibitors Influence Skeletal Muscle Pathology in Patients With HFrEF
- Association of ADHD Pharmacotherapy With Mortality in Individuals With ADHD
- Exposure–Response Associations Between Chronic Exposure to Fine Particulate Matter and Risks of Hospital Admission for Major CVD
- Association of Opioid Analgesic Use With Age-Related Risk of Serious Fall Events
- Association of Low-Dose Aspirin Use With Prevention of Colorectal Cancer
- Aspirin and Cardiovascular Risk in Individuals With Elevated Lp(a) Levels
- Effect of Tirzepatide on Blood Pressure Levels in Individuals With Overweight or Obesity Without Diabetes
- Effect of Bempedoic Acid on the Risk of Total Cardiovascular Events
- Efficacy of Voice-Based Conversational AI for the Titration of Insulin Among Patients With Type 2 Diabetes
- SARS-CoV-2 Precipitates Pro-Atherogenic Inflammatory Responses in Coronary Vessels